These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27979502)

  • 1. Digital PCR quantification of miR-30c and miR-181a as serum biomarkers for Duchenne muscular dystrophy.
    Llano-Diez M; Ortez CI; Gay JA; Álvarez-Cabado L; Jou C; Medina J; Nascimento A; Jimenez-Mallebrera C
    Neuromuscul Disord; 2017 Jan; 27(1):15-23. PubMed ID: 27979502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.
    Trifunov S; Natera-de Benito D; Exposito Escudero JM; Ortez C; Medina J; Cuadras D; Badosa C; Carrera L; Nascimento A; Jimenez-Mallebrera C
    Front Neurol; 2020; 11():304. PubMed ID: 32373058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.
    Matsuzaka Y; Kishi S; Aoki Y; Komaki H; Oya Y; Takeda S; Hashido K
    Environ Health Prev Med; 2014 Nov; 19(6):452-8. PubMed ID: 25150707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy.
    Hu J; Kong M; Ye Y; Hong S; Cheng L; Jiang L
    J Neurochem; 2014 Jun; 129(5):877-83. PubMed ID: 24460924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.
    Zaharieva IT; Calissano M; Scoto M; Preston M; Cirak S; Feng L; Collins J; Kole R; Guglieri M; Straub V; Bushby K; Ferlini A; Morgan JE; Muntoni F
    PLoS One; 2013; 8(11):e80263. PubMed ID: 24282529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating MicroRNAs in Duchenne Muscular Dystrophy.
    Mousa NO; Abdellatif A; Fahmy N; Zada S; El-Fawal H; Osman A
    Clin Neurol Neurosurg; 2020 Feb; 189():105634. PubMed ID: 31838454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as serum biomarkers in Becker muscular dystrophy.
    Gagliardi D; Rizzuti M; Brusa R; Ripolone M; Zanotti S; Minuti E; Parente V; Dioni L; Cazzaniga S; Bettica P; Bresolin N; Comi GP; Corti S; Magri F; Velardo D
    J Cell Mol Med; 2022 Sep; 26(17):4678-4685. PubMed ID: 35880500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miRNA-29, -23 and -21 in urine of Duchenne muscular dystrophy patients.
    Catapano F; Domingos J; Perry M; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Niks EH; Verschuuren JJ; Straub V; Voit T; Morgan J; Muntoni F
    Epigenomics; 2018 Jul; 10(7):875-889. PubMed ID: 29564913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in Golden Retriever muscular dystrophy dogs and Duchenne muscular dystrophy patients.
    Jeanson-Leh L; Lameth J; Krimi S; Buisset J; Amor F; Le Guiner C; Barthélémy I; Servais L; Blot S; Voit T; Israeli D
    Am J Pathol; 2014 Nov; 184(11):2885-98. PubMed ID: 25194663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs as a Tool for Differential Diagnosis of Neuromuscular Disorders.
    Mousa NO; Abdellatif A; Fahmy N; El-Fawal H; Osman A
    Neuromolecular Med; 2023 Dec; 25(4):603-615. PubMed ID: 37856057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel free-circulating and extracellular vesicle-derived miRNAs dysregulated in Duchenne muscular dystrophy.
    Catapano F; Scaglioni D; Maresh K; Ala P; Domingos J; Selby V; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Voit T; Verschuuren JJGM; Niks EH; Straub V; Morgan J; Muntoni F
    Epigenomics; 2020 Nov; 12(21):1899-1915. PubMed ID: 33215544
    [No Abstract]   [Full Text] [Related]  

  • 12. miRNAs as serum biomarkers for Duchenne muscular dystrophy.
    Cacchiarelli D; Legnini I; Martone J; Cazzella V; D'Amico A; Bertini E; Bozzoni I
    EMBO Mol Med; 2011 May; 3(5):258-65. PubMed ID: 21425469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNome profiling in Duchenne muscular dystrophy; identification of asymptomatic and manifesting female carriers.
    Mousa NO; Sayed AA; Fahmy N; Elzayat MG; Bakry U; Abdellatif A; Zahra WK; Osman A
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34472584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibronectin is a serum biomarker for Duchenne muscular dystrophy.
    Cynthia Martin F; Hiller M; Spitali P; Oonk S; Dalebout H; Palmblad M; Chaouch A; Guglieri M; Straub V; Lochmüller H; Niks EH; Verschuuren JJ; Aartsma-Rus A; Deelder AM; van der Burgt YE; 't Hoen PA
    Proteomics Clin Appl; 2014 Apr; 8(3-4):269-78. PubMed ID: 24458521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum MyomiRs as Biomarkers for Female Carriers of Duchenne/Becker Muscular Dystrophy.
    Zhang J; Meng Q; Zhong J; Zhang M; Qin X; Ni X; Ma J; He Y; Zeng D; Lan D
    Front Neurol; 2020; 11():563609. PubMed ID: 33071947
    [No Abstract]   [Full Text] [Related]  

  • 16. miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context.
    Guilbaud M; Gentil C; Peccate C; Gargaun E; Holtzmann I; Gruszczynski C; Falcone S; Mamchaoui K; Ben Yaou R; Leturcq F; Jeanson-Leh L; Piétri-Rouxel F
    Skelet Muscle; 2018 Apr; 8(1):15. PubMed ID: 29703249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum creatinine level: a supplemental index to distinguish Duchenne muscular dystrophy from Becker muscular dystrophy.
    Zhang H; Zhu Y; Sun Y; Liang Y; Li Y; Zhang Y; Deng L; Wen X; Zhang C
    Dis Markers; 2015; 2015():141856. PubMed ID: 25852218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy.
    Hrach HC; Mangone M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy.
    Rouillon J; Zocevic A; Leger T; Garcia C; Camadro JM; Udd B; Wong B; Servais L; Voit T; Svinartchouk F
    Neuromuscul Disord; 2014 Jul; 24(7):563-73. PubMed ID: 24813925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD).
    Nadarajah VD; van Putten M; Chaouch A; Garrood P; Straub V; Lochmüller H; Ginjaar HB; Aartsma-Rus AM; van Ommen GJ; den Dunnen JT; 't Hoen PA
    Neuromuscul Disord; 2011 Aug; 21(8):569-78. PubMed ID: 21724396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.